Background: The prevalence of opium addiction in Iran is high probably due to the belief that opium has preventive effects against cardiovascular diseases. In the second phase of Kerman coronary artery disease risk factors study, the prevalence, incidence rate, and the association between opium use and other coronary artery disease risk factors (CADRFs) were assessed. Methods: In a cross-sectional study (2014-2018), 9996 inhabitants of Kerman, southeastern Iran, aged 15-80 years were recruited to the study. After taking fasting blood samples, the participants were examined or interviewed for demographic data and CADRFs, including opium use. The participants were categorized into “never”, “occasional”, and “dependent” users. The association between opium use and CADRFs was assessed with adjusted regression analysis (Stata v.11 software). Results: The overall prevalence of opium consumption was lower than that of five years earlier (P<0.01). The prevalence was currently higher in men than women and decreased in men between the two phases (P<0.001). There was a positive correlation between opium use and depression (P<0.001), anxiety (P<0.05), and a negative association with the level of physical activity (P<0.001). The five-year incident rate of dependent and occasional opium use was 4.2 and 3.9 persons/100 person-years, respectively. The incidence of opium use was higher in diabetic, hypertensive, depressed, anxious, and obese subjects. Conclusion: The study did not demonstrate any protective effects of opium on CADRFs. Considering the higher rate of opium use in subjects with hypertension, diabetes, obesity, and psychological disorders, the health authorities should implement educational programs to warn and correct the unsafe belief. |
- Network GBoDC. Global burden of disease study 2017 (GBD 2017) results. Seattle, United States: Institute for Health Metrics and Evaluation (IHME). 2018.
- UNODC. World Drug Report (United Nations Office on Drugs and Crime). Vienna: United Nations Office on Drugs and Crime; 2020.
- Mohebbi E, Haghdoost AA, Noroozi A, Molavi Vardanjani H, Hajebi A, Nikbakht R, et al. Awareness and Attitude Towards Opioid and Stimulant Use and Lifetime Prevalence of the Drugs: A Study in 5 Large Cities of Iran. Int J Health Policy Manag. 2019;8:222-32. doi: 10.15171/ijhpm.2018.128. PubMed PMID: 31050967; PubMed Central PMCID: PMCPMC6499902.
- Amin-Esmaeili M, Rahimi-Movaghar A, Sharifi V, Hajebi A, Radgoodarzi R, Mojtabai R, et al. Epidemiology of illicit drug use disorders in Iran: prevalence, correlates, comorbidity and service utilization results from the Iranian Mental Health Survey. Addiction. 2016;111:1836-47. doi: 10.1111/add.13453. PubMed PMID: 27177849.
- Bashardoost N, Tirani M. Prevalence of addiction in males: Isfahan 2003. ARYA Atherosclerosis. 2010;1.
- Menati W, Valizadeh R, Menati R, Niazi M, Nazarzadeh M, Bidel Z. Determination of opium abuse prevalence in Iranian young people: a systematic review and meta-analysis. Journal of Substance Use. 2017;22:3-10. doi: 10.3109/14659891.2015.1130181.
- Masoomi M, Ramezani MA, Karimzadeh H. The relationship of opium addiction with coronary artery disease. Int J Prev Med. 2010;1:182-6. PubMed PMID: 21566789; PubMed Central PMCID: PMCPMC3075529.
- Esmaeili Nadimi A, Pour Amiri F, Sheikh Fathollahi M, Hassanshahi G, Ahmadi Z, Sayadi AR. Opium addiction as an independent risk factor for coronary microvascular dysfunction: A case-control study of 250 consecutive patients with slow-flow angina. Int J Cardiol. 2016;219:301-7. doi: 10.1016/j.ijcard.2016.06.034. PubMed PMID: 27343424.
- Ziaee M, Hajizadeh R, Khorrami A, Sepehrvand N, Momtaz S, Ghaffari S. Cardiovascular Complications of Chronic Opium Consumption: A Narrative Review Article. Iran J Public Health. 2019;48:2154-64. PubMed PMID: 31993383; PubMed Central PMCID: PMCPMC6974854.
- Fallahzadeh MA, Salehi A, Naghshvarian M, Fallahzadeh MH, Poustchi H, Sepanlou SG, et al. Epidemiologic Study of Opium Use in Pars Cohort Study: A Study of 9000 Adults in a Rural Southern Area of Iran. Arch Iran Med. 2017;20:205-10. doi: 0172004/AIM.004. PubMed PMID: 28412823.
- Sadeghian S, Boroumand MA, Sotoudeh-Anvari M, Rabbani S, Sheikhfathollahi M, Abbasi A. Effect of opium on glucose metabolism and lipid profiles in rats with streptozotocin-induced diabetes. Endokrynol Pol. 2009;60:258-62. PubMed PMID: 19753539.
- Rezvanfar MR, Farahany H, Rafiee M, Kaboli S. Opium consumption challenge and diabetes mellitus control. Iranian Journal of Diabetes and Obesity. 2011;3:72-6.
- Mahmoodi M, Hosseini-Zijoud S-M, Hosseini J, Sayyadi A, Hajizadeh M, Hassanshahi G, et al. Opium withdrawal and some blood biochemical factors in addicts’ individuals. Advances in biological chemistry. 2012;2:167-70. doi: 10.4236/abc.2012.22020.
- Asgary S, Naderi G, Soghraty M, Ahmady P, Shahrezaee J. A study of plasma lipid peroxidation, lipids and blood sugar level in opium addicts compared with control group. ARYA Atherosclerosis. 2010;1.
- Kouros D, Tahereh H, Mohammadreza A, Minoo MZ. Opium and heroin alter biochemical parameters of human’s serum. Am J Drug Alcohol Abuse. 2010;36:135-9. doi: 10.3109/00952991003734277. PubMed PMID: 20465370.
- Najafipour H, Masoomi M, Shahesmaeili A, Haghdoost AA, Afshari M, Nasri HR, et al. Effects of opium consumption on coronary artery disease risk factors and oral health: Results of Kerman Coronary Artery Disease Risk factors Study a population-based survey on 5900 subjects aged 15-75 years. Int J Prev Med. 2015;6:42. doi: 10.4103/2008-7802.157470. PubMed PMID: 26097671; PubMed Central PMCID: PMCPMC4455126.
- World Medical A. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310:2191-4. doi: 10.1001/jama.2013.281053. PubMed PMID: 24141714.
- Najafipour H, Mirzazadeh A, Haghdoost A, Shadkam M, Afshari M, Moazenzadeh M, et al. Coronary Artery Disease Risk Factors in an Urban and Peri-urban Setting, Kerman, Southeastern Iran (KERCADR Study): Methodology and Preliminary Report. Iran J Public Health. 2012;41:86-92. PubMed PMID: 23193513; PubMed Central PMCID: PMCPMC3494222.
- Osman A, Kopper BA, Barrios FX, Osman JR, Wade T. The Beck Anxiety Inventory: reexamination of factor structure and psychometric properties. J Clin Psychol. 1997;53:7-14. doi: 10.1002/(sici)1097-4679(199701)53:1<7::aid-jclp2>3.0.co;2-s. PubMed PMID: 9120035.
- Jackson-Koku G. Beck Depression Inventory. Occup Med (Lond). 2016;66:174-5. doi: 10.1093/occmed/kqv087. PubMed PMID: 26892598.
- Herrmann SD, Heumann KJ, Der Ananian CA, Ainsworth BE. Validity and reliability of the global physical activity questionnaire (GPAQ). Measurement in Physical Education and Exercise Science. 2013;17:221-35. doi: 10.1080/1091367X.2013.805139.
- Morris CK, Myers J, Froelicher VF, Kawaguchi T, Ueshima K, Hideg A. Nomogram based on metabolic equivalents and age for assessing aerobic exercise capacity in men. J Am Coll Cardiol. 1993;22:175-82. doi: 10.1016/0735-1097(93)90832-l. PubMed PMID: 8509539.
- Organization WH. Dentition status and criteria for diagnosis and coding (Caries). Geneva: WHO Oral Health Surveys: Basic methods. 1997:39-44.
- Greene JC, Vermillion JR. The Simplified Oral Hygiene Index. J Am Dent Assoc. 1964;68:7-13. doi: 10.14219/jada.archive.1964.0034. PubMed PMID: 14076341.
- Hasin D, Hatzenbuehler ML, Keyes K, Ogburn E. Substance use disorders: Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV) and International Classification of Diseases, tenth edition (ICD-10). Addiction. 2006;101:59-75. doi: 10.1111/j.1360-0443.2006.01584.x. PubMed PMID: 16930162.
- Dicker RC, Coronado F, Koo D, Parrish RG. Principles of epidemiology in public health practice; an introduction to applied epidemiology and biostatistics. Atlanta: CDC Stacks; 2006.
- Dhar AK, Barton DA. Depression and the Link with Cardiovascular Disease. Front Psychiatry. 2016;7:33. doi: 10.3389/fpsyt.2016.00033. PubMed PMID: 27047396; PubMed Central PMCID: PMCPMC4800172.
- Fluharty M, Taylor AE, Grabski M, Munafo MR. The Association of Cigarette Smoking With Depression and Anxiety: A Systematic Review. Nicotine Tob Res. 2017;19:3-13. doi: 10.1093/ntr/ntw140. PubMed PMID: 27199385; PubMed Central PMCID: PMCPMC5157710.
- Najafipour H, Beik A. The Impact of Opium Consumption on Blood Glucose, Serum Lipids and Blood Pressure, and Related Mechanisms. Front Physiol. 2016;7:436. doi: 10.3389/fphys.2016.00436. PubMed PMID: 27790151; PubMed Central PMCID: PMCPMC5061814.
- Moezi Bady SA, Soltani M, Kazemi T, Khosravi Bizhaem S, Hanafi Bojd N, Partovi N, et al. Surveying the Effect of Opioid Abuse on the Extent of Coronary Artery Diseases in Diabetic Patients. J Addict. 2020;2020:8619805. doi: 10.1155/2020/8619805. PubMed PMID: 32765923; PubMed Central PMCID: PMCPMC7387960.
- Golozar A, Khademi H, Kamangar F, Poutschi H, Islami F, Abnet CC, et al. Diabetes mellitus and its correlates in an Iranian adult population. PLoS One. 2011;6:e26725. doi: 10.1371/journal.pone.0026725. PubMed PMID: 22053206; PubMed Central PMCID: PMCPMC3203882.
- Mami S, Eghbali M, Cheraghi J, Mami F, Borujeni MP, Salati AP. Effect of opium addiction on some serum parameters in rabbit. Glob Vet. 2011;7:310-4.
- Holmlund A, Lampa E, Lind L. Oral health and cardiovascular disease risk in a cohort of periodontitis patients. Atherosclerosis. 2017;262:101-6. doi: 10.1016/j.atherosclerosis.2017.05.009. PubMed PMID: 28531825.
- Najafipour H, Afshari M, Rostamzadeh F. Prevalence of Multiple Coronary Artery Disease Risk Factors in Kerman: A Population-Based Study in Southeast Iran. Iran J Med Sci. 2018;43:140-9. PubMed PMID: 29749982; PubMed Central PMCID: PMCPMC5936845.
|